DUBLIN–(BUSINESS WIRE)–The “Fetal Monitoring Market Analysis by Product (Consumables & Instruments, Services), by Portability (Portable, Non-Portable), by Method (Invasive, Non-Invasive), by Application (Intrapartum, Antepartum), by End-Use and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global fetal monitoring market size is estimated to be USD 3.95 billion in 2021 and is expected to witness a CAGR of 7.56% during the forecast period.
Rising incidences of cardiopulmonary illness and preterm births coupled with birth complications is a key driver for the growth of the global fetal monitoring market.
Additionally, the increase in prevalence of fetal transmittable diseases, cross-infection cases during the COVID-19 pandemic, growing health awareness & medical expenditure, and rising complications in pregnancy are some of the other drivers propelling the market growth.
Nevertheless, the expensive equipment cost and robust regulatory framework for illegal monitoring of foetus are expected to restrain the global market growth.
By Product
Based on product, the market is segmented into services and consumables & instruments. In 2021, the consumables & instruments segment accounted for the largest revenue share with lucrative CAGR during the forecast period. This is attributed to the growing rate of maternal mortality, irregularity in birth rate, supportive government initiatives for antepartum haemorrhage rate, & parental care coupled with technological advancement worldwide. Services segment projected to grow at a profitable CAGR during the forecast period. This is attributed to rising awareness for fetal care and monitoring, thereby by minimized miscarriages and abnormal neonate birth rate.
By Portability
Based on technology, the market is categorized into portable and non-portable. In 2021, the non-portable segment accounted for the largest revenue share due to increasing adoption among medical practitioners worldwide. The portable segment is anticipated to grow at a significant CAGR during the forecast period, due to the growing awareness, increasing home-care services, and novel product development with digital integration.
By Method
Based on technology, the market is categorized into invasive and non-invasive. In 2021, the non-invasive method accounted for the maximum revenue share due to high adoption and safer monitoring without fetal infection worldwide. This segment is anticipated to grow at a lucrative CAGR during the forecast period, due to the affordability, convenient monitoring, and rising R&D by medical device manufacturers.
By Application
Based on application, the market is categorized into intrapartum fetal monitoring and antepartum fetal monitoring. The antepartum fetal monitoring segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The increasing prevalence of congenital anomalies coupled with advanced product development is a key factor that drives the segment growth.
By End-Use
Based on end-use, the market is categorized into hospitals and speciality clinics. The hospitals’ segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The rising patient consultation & admission in hospital and advanced medical infrastructure with comprehensive services is a key factor that drives the segment growth. The speciality clinics’ segment is anticipated to grow at the fastest CAGR during the forecast period owing to technological advancement.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of advanced healthcare infrastructure, large hospitals with well-established medical insurance system, and high awareness in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of fetal abnormalities, escalating demand for advanced medication and treatment, strengthening regional economic conditions, and growing focus of medical device manufacturers in this region.
Competitor Insights
Some of the key players in the fetal monitoring market are OSI Systems, Inc. (U.S.); Natus Medical Incorporated (U.S.); Neoventa Medical AB (Sweden); Arjo (Sweden); Medtronic plc (Ireland.); Siemens AG (Germany); Koninklijke Philips N.V. (Netherlands); General Electric Company (U.S.); FUJIFILM Holdings (Japan); and Analogic Corporation (U.S.). The leading players operating in the fetal monitoring industry are adopting various strategies including R&D investments, adaption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The fetal monitoring market report is categorized into the following segments and subsegments:
For more information about this report visit https://www.researchandmarkets.com/r/7jl8db
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
